Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

Rituximab maintenance (RM) prolongs the progression-free survival (PFS) of responding patients with follicular lymphoma (FL), but the maintenance efficacy in different Follicular Lymphoma International Prognostic Index (FLIPI) risk group is still confusing. We performed a retrospective analysis of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ru, Wang, Tingyu, Lyv, Rui, Wang, Yi, Yu, Ying, Yan, Yuting, Sun, Qi, Xiong, Wenjie, Liu, Wei, Sui, Weiwei, Huang, Wenyang, Wang, Huijun, Li, Chengwen, Wang, Jun, Zou, Dehui, An, Gang, Wang, Jianxiang, Qiu, Lugui, Yi, Shuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205248/
https://www.ncbi.nlm.nih.gov/pubmed/37228779
http://dx.doi.org/10.1097/BS9.0000000000000144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205248/
https://www.ncbi.nlm.nih.gov/pubmed/37228779
http://dx.doi.org/10.1097/BS9.0000000000000144

Ejemplares similares